REEP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.849600E-01
Normal-vs-Stage2
1.281590E-01
Normal-vs-Stage3
5.758800E-01
Normal-vs-Stage4
2.152800E-01
Stage1-vs-Stage2
2.904000E-01
Stage1-vs-Stage3
7.654600E-01
Stage1-vs-Stage4
2.678600E-01
Stage2-vs-Stage3
2.496800E-01
Stage2-vs-Stage4
4.860600E-01
Stage3-vs-Stage4
2.796200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.786190E-01
Normal-vs-AfricanAmerican
1.378760E-01
Normal-vs-Asian
1.724390E-01
Caucasian-vs-AfricanAmerican
3.857400E-01
Caucasian-vs-Asian
7.580400E-01
AfricanAmerican-vs-Asian
3.217200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.480200E-01
Normal-vs-Female
1.847970E-01
Male-vs-Female
8.582600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.267000E-01
Normal-vs-Age(41-60Yrs)
6.660300E-02
Normal-vs-Age(61-80Yrs)
2.149400E-01
Normal-vs-Age(81-100Yrs)
2.317200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.017000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.910800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.032600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.631900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.567100E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.831350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.165600E-01
Normal-vs-Daily Drinker
2.981000E-01
Normal-vs-Weekly Drinker
1.534630E-01
Normal-vs-Occasional Drinker
5.076200E-02
Normal-vs-Social Drinker
1.375770E-01
Non Drinker-vs-Daily Drinker
9.504800E-01
Non Drinker-vs-Weekly Drinker
9.596200E-01
Non Drinker-vs-Occasional Drinker
4.829700E-02
Non Drinker-vs-Social Drinker
4.626000E-01
Daily Drinker-vs-Weekly Drinker
9.230400E-01
Daily Drinker-vs-Occasional Drinker
7.720200E-02
Daily Drinker-vs-Social Drinker
4.918600E-01
Weekly Drinker-vs-Occasional Drinker
9.046200E-02
Weekly Drinker-vs-Social Drinker
5.289400E-01
Occasional Drinker-vs-Social Drinker
3.024000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.537600E-01
Normal-vs-Grade 2
2.674300E-02
Normal-vs-Grade 3
2.890500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.617500E-03
Grade 1-vs-Grade 3
4.841900E-03
Grade 1-vs-Grade 4
2.537600E-01
Grade 2-vs-Grade 3
3.914800E-01
Grade 2-vs-Grade 4
2.674300E-02
Grade 3-vs-Grade 4
2.890500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.085400E-01
Normal-vs-NonDiabetic
1.528650E-01
Diabetic-vs-NonDiabetic
8.841000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.673600E-02
Normal-vs-NoPancreatitis
1.675960E-01
Pancreatitis-vs-NoPancreatitis
6.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.050000E-01
Normal-vs-N1
1.398430E-01
N0-vs-N1
3.871400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.322300E-02
Normal-vs-TP53-NonMutant
3.458800E-01
TP53-Mutant-vs-TP53-NonMutant
4.30449999999638E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
